Capricor yo-yos as J&J dumps stem cell partnership – FierceBiotech
|
Capricor yo-yos as J&J dumps stem cell partnership
FierceBiotech After three and a half years, Johnson & Johnson is ducking out of a partnership with Capricor Therapeutics focused on the use of stem cells to treat cardiovascular disease. The decision by J&J's Janssen unit not to pursue a license comes as little … |
